Cigna Group, US1255231003

Cigna Group stock holds at USD 272.01 before investor day

Published on 09/29/2026 at 06:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cigna Group stock faces its September 30 investor day after adjusted Q2 2026 EPS reached USD 7.78 against USD 7.60 consensus. Evercore set a USD 290.00 target.

Modernes Bürogebäude eines US-Krankenversicherers mit Glasfassade und gepflegtem Außengelände
Cigna Group Krankenversicherung modernes Unternehmensgebäude mit Glasfassade, ISIN US1255231003, Mitarbeiter gehen zum Eingang, Illustration mit AI erstellt.

Cigna Group stock was last at USD 272.01 on the NYSE on September 28, 2026, with a reported change of 0.00 percent. The next major company date is the September 30, 2026, investor day, where pharmacy benefit management strategy is central to the investment case.

Investor day sets the next test

Investing.com reported on September 9, 2026, that Evercore ISI began coverage with an In Line rating and a USD 290.00 price target. The firm cited execution risk as Cigna transitions its pharmacy benefit management business toward a rebate-free model.

The date matters because the pharmacy benefit management operation is a major earnings driver. Evercore projected adjusted operating income growth of 2.00 percent from 2026 to 2030 for the pharmacy services business and said its operating margin could reach 1.60 percent in 2028, compared with 2.70 percent in 2025.

Quarterly earnings provide support

According to MarketBeat, Cigna reported adjusted Q2 2026 earnings per share of USD 7.78, above the USD 7.60 consensus estimate. Quarterly revenue was USD 70.04 billion, up 6.70 percent from the prior-year quarter, while the prior-year earnings figure was USD 7.20.

The earnings comparison is mixed in an important way. Adjusted EPS exceeded consensus by USD 0.18, but reported revenue of USD 70.04 billion was below the USD 70.14 billion estimate cited by MarketBeat, leaving the investor day to clarify how much future growth depends on execution rather than volume alone.

Valuation leaves a clear comparison

Cigna Group's USD 272.01 reference price stood USD 17.99 below Evercore's USD 290.00 target, while the broader analyst average reported by MarketBeat was USD 337.10. The stock's 52-week range was USD 239.51 to USD 315.47 as of September 25, 2026, placing the reference price inside the established yearly band.

The market capitalization was USD 71.9 billion as of September 25, 2026. For investors, the September 30 presentation is therefore less about the latest quarterly beat than about whether Cigna can protect profitability while changing the economics of its pharmacy benefit management business.

Stock holds before the company date

Cigna Group stock was last at USD 272.01 on the NYSE on September 28, 2026, with a 0.00 percent reported change. The company enters the September 30 investor day with Q2 adjusted EPS above consensus and a pharmacy transition that remains the key operating issue.

Cigna Group stock snapshot

  • Company: The Cigna Group
  • ISIN: US1255231003
  • Ticker: CI
  • Trading venue: NYSE
  • Price (as of September 28, 2026): USD 272.01, last at
  • Market capitalization: USD 71.9 billion (as of September 25, 2026)
  • 52-week range: USD 239.51-315.47 (as of September 25, 2026)
  • Sector / Industry: Healthcare / Healthcare Providers and Services

More news and analyses on Cigna Group stock

Disclaimer...

en | US1255231003 | CIGNA GROUP | boerse | 70196038 | bgmi